Company news
Medigen Vaccine Biologics Corp. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market
March 17, 2026
Announcement of the company's resolutions on the stock dividend ex-rights base date
July 14, 2022
Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase
July 1, 2022
Medigen Vaccine Biologics: Subscription rights to the cash issue forfeited by directors of the Company reaching 50% and subscription being made available to specific persons
June 10, 2022
Additional update on clinical development on MVC COVID-19 vaccine in the WHO COVID-19 Solidarity Trial Vaccines (Supplementary Announcement)
June 8, 2022
The manufacturing facility of MVC EV71 Vaccine obtained PIC/S GMP certificate from the Ministry of Health and Welfare (MOHW)
June 7, 2022
MVC file provisional approval application of COVID-19 Vaccine to Therapeutic Goods Administration
June 6, 2022
Announcement the institution designated to collect and deposit for 1st domestic unsecured convertible corporate bonds
April 22, 2022
Announcement of the company's cash capital increase subscription date and other related matters (supplemental issue price and banks information)
April 21, 2022
Announcement of the company's cash capital increase subscription date and other related matters
April 13, 2022
Resolution by the board of directors to distribute dividends
April 6, 2022
Resolution to issue new shares for capital increase through profits by Board of Directors
March 1, 2022
Medigen Vaccine Biologics: Board of directors has resolved to issue 1st of unsecured convertible corporate bonds
March 1, 2022
Announcement of the company's board of directors resolution of cash capital increase issue of new shares
March 1, 2022
Announcement of the board of directors'resolution the date of the shareholders' meeting
March 1, 2022
Medigen Vaccine Biologics: Paraguay approves the Emergency Use Authorization (EUA) of MVC COVID-19 Vaccine
February 14, 2022
The interim analysis results of MVC COVID-19 Vaccine phase 3 clinical trial in Paraguay meet the criteria of superiority
February 14, 2022